Anthropic's Export Control Backfire Is Now DeepSeek's $7.4B Windfall

Frequently asked

What does a 99% token price cut by Chinese AI labs mean for companies already under US AI vendor contracts?

It means the cost justification for those contracts is under immediate pressure. Procurement teams renewing or negotiating US frontier model agreements now have a documented Chinese alternative priced at a fraction of the cost. The controls that were supposed to protect US vendors have handed the price argument to their competitors.

Why did export controls on Anthropic's models accelerate DeepSeek's funding rather than slow it?

Restricting US model access signaled to Chinese investors that a domestic alternative had strategic urgency — and made DeepSeek's pitch easier, not harder. The cutoff validated the market gap DeepSeek was filling. Capital followed the signal the controls created, not the intent behind them.

What is the strongest argument that the export controls were still the right call despite the DeepSeek outcome?

The strongest counter is that DeepSeek's funding trajectory was already underway and the timing correlation does not establish causation — a lab that size raises at scale regardless of US policy. If true, the controls still delay capability transfer at the model level even if they cannot stop capital formation. The timing, however, makes that argument expensive to hold publicly.

More on this wire